MAGNITUDE AND TIMING OF CHANGE IN MONITORING PARAMETERS FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY PATIENTS TREATED AND UNTREATED WITH TAFAMIDIS

被引：0
|
作者：
Shahi, Karan [1 ]
Miller, Robert Jh [1 ]
Dykstra, Steven [1 ]
Feng, Yuanchao [1 ]
Howlett, Jonathan G. [1 ]
Kassam, Shireen [1 ]
Veenhuyzen, Jan [1 ]
White, James [1 ]
Fine, Nowell Mark [1 ]
机构：
[1] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1305-123
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [31] Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
    Fontana, Marianna
    Berk, John L.
    Gillmore, Julian D.
    Witteles, Ronald M.
    Grogan, Martha
    Drachman, Brian
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Taubel, Jorg
    Solomon, Scott D.
    Sheikh, Farooq H.
    Tahara, Nobuhiro
    Gonzalez-Costello, Jose
    Tsujita, Kenichi
    Morbach, Caroline
    Pozsonyi, Zoltan
    Petrie, Mark C.
    Delgado, Diego
    van der Meer, Peter
    Jabbour, Andrew
    Bondue, Antoine
    Kim, Darae
    Azevedo, Olga
    Hvitfeldt Poulsen, Steen
    Yilmaz, Ali
    Jankowska, Ewa A.
    Algalarrondo, Vincent
    Slugg, Andrew
    Garg, Pushkal P.
    Boyle, Katherine L.
    Yureneva, Elena
    Silliman, Nancy
    Yang, Lilli
    Chen, Jihong
    Eraly, Satish A.
    Vest, John
    Maurer, Mathew S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (01): : 33 - 44
  • [32] Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Wollenweber, Tim
    Duca, Franz
    Binder, Christina
    Cherouny, Bernhard
    Dachs, Theresa-Marie
    Ligios, Luciana Camuz
    Schrutka, Lore
    Dalos, Daniel
    Beitzke, Dietrich
    Loewe, Christian
    Eslam, Roza Badr
    Kastner, Johannes
    Hacker, Marcus
    Bonderman, Diana
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (08) : 1019 - 1030
  • [33] Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy
    Takashio, S.
    Morioka, M.
    Fujiyama, A.
    Oike, F.
    Hanatani, S.
    Usuku, H.
    Yamamoto, E.
    Matsushita, K.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2022, 43 : 964 - 964
  • [34] Safety and efficacy of tafamidis in Chinese patients with transthyretin amyloid cardiomyopathy
    Tian, Zhuang
    Peng, Daoquan
    Ma, Wei
    Yan, Jiangtao
    Wang, Jian'an
    Jin, Wei
    Tang, Yida
    Liu, Ying
    Jia, Caiping
    Gao, Yingxu
    Sun, Qiankun
    Angeli, Franca S.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S2 - S3
  • [35] Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: improved long-term survival
    Tubben, Alwin
    Nienhuis, Hans L. A.
    van der Meer, Peter
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (11) : 2065 - 2066
  • [36] Clinical course of the first 26 patients with cardiac transthyretin-amyloidosis treated with Tafamidis in our center
    Danninger, K.
    Aigner, M.
    Alberer, M.
    Binder, R. K.
    Weber, T.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 150 - 151
  • [37] Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid Cardiomyopathy
    Psotka, Mitchell A.
    JACC-HEART FAILURE, 2021, 9 (02) : 124 - 126
  • [38] Mortality Among Older Transthyretin Amyloid Cardiomyopathy Patients On Tafamidis
    Batra, Supria
    Patel, Hina
    Govi, Ashley
    Panjrath, Gurusher
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [39] Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy
    Paton, D. M.
    DRUGS OF TODAY, 2019, 55 (12) : 727 - 734
  • [40] Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis
    Ichikawa, Yasushi
    Oota, Eri
    Odajima, Susumu
    Kintsu, Masayuki
    Todo, Saki
    Takeuchi, Kimikazu
    Yamauchi, Yuki
    Shiraki, Hiroaki
    Yamashita, Kentaro
    Fukuda, Terunobu
    Hisamatsu, Eriko
    Hirata, Ken-ichi
    Tanaka, Hidekazu
    CIRCULATION JOURNAL, 2023, 87 (04) : 508 - 516
12345